Preserved Value of Bone Scintigraphy for the Detection of Skeletal Metastases in Prostate Cancer Patients with Low Prostate-Specific Antigen Levels

MELTEM CAGLAR; MURAT TUNCEL

doi:10.1097/00003072-200207000-00017

Preserved Value of Bone Scintigraphy for the Detection of Skeletal Metastases in Prostate Cancer Patients with Low Prostate-Specific Antigen Levels

Clinical Nuclear Medicine ◽

10.1097/00003072-200207000-00017 ◽

2002 ◽

Vol 27 (7) ◽

pp. 532-533 ◽

Cited By ~ 2

Author(s):

MELTEM CAGLAR ◽

MURAT TUNCEL

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Bone Scintigraphy ◽

Specific Antigen ◽

Skeletal Metastases

Download Full-text

Predictive value of serum prostate specific antigen in detecting bone metastasis in prostate cancer patients using bone scintigraphy

Indian Journal of Nuclear Medicine ◽

10.4103/0972-3919.110683 ◽

2012 ◽

Vol 27 (2) ◽

pp. 81 ◽

Cited By ~ 9

Author(s):

BhagwantRai Mittal ◽

Chidambaram NatrajanBalasubramanian Harisankar ◽

Anish Bhattacharya ◽

ShrawanKumar Singh ◽

ArupK Mandal ◽

...

Keyword(s):

Prostate Cancer ◽

Bone Metastasis ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Bone Scintigraphy ◽

Predictive Value ◽

Specific Antigen ◽

Serum Prostate Specific Antigen

Download Full-text

A comparative study of prostate specific antigen (PSA), C-terminal propeptide of blood type I procollagen (PICP) and urine type I collagen-crosslinked N telopeptide (NTx) levels using bone scintigraphy in prostate cancer patients

Annals of Nuclear Medicine ◽

10.1007/bf02988524 ◽

2003 ◽

Vol 17 (4) ◽

pp. 297-303 ◽

Cited By ~ 4

Author(s):

Nobuyoshi Fukumitsu ◽

Mayuki Uchiyama ◽

Yutaka Mori ◽

Kouichi Kishimoto ◽

Jojiro Nakada

Keyword(s):

Prostate Cancer ◽

Comparative Study ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Bone Scintigraphy ◽

Type I Collagen ◽

Specific Antigen ◽

Blood Type ◽

Type I ◽

Type I Procollagen

Download Full-text

Prostate-specific antigen for prediction of skeletal metastases on bone scintigraphy in prostate cancer

World Journal of Nuclear Medicine ◽

10.4103/wjnm.wjnm_129_20 ◽

2021 ◽

Vol 20 (3) ◽

pp. 327

Author(s):

EmmanuelNii Boye Hammond ◽

YawAmpem Amoako ◽

DennisOdai Laryea ◽

George Amoah

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Bone Scintigraphy ◽

Specific Antigen ◽

Skeletal Metastases

Download Full-text

Nadir Prostate-Specific Antigen After Neoadjuvant Androgen Suppression (AS) in Prostate Cancer Patients Receiving Short-term AS and Radiation Therapy: Pooled Analysis of Four NRG Oncology/RTOG Randomized Clinical Trials

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.111 ◽

2015 ◽

Vol 93 (3) ◽

pp. S46

Author(s):

C.L. Hallemeier ◽

P. Zhang ◽

T.M. Pisansky ◽

G.E. Hanks ◽

D.G. McGowan ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Radiation Therapy ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Randomized Clinical Trials ◽

Specific Antigen ◽

Pooled Analysis ◽

Short Term ◽

Androgen Suppression

Download Full-text

Detection of N,N-diacetyllactosamine (LacdiNAc) containing free prostate-specific antigen for early stage prostate cancer diagnostics and for identification of castration-resistant prostate cancer patients

Bioorganic & Medicinal Chemistry ◽

10.1016/j.bmc.2021.116156 ◽

2021 ◽

Vol 39 ◽

pp. 116156

Author(s):

Aniko Bertokova ◽

Tomas Bertok ◽

Eduard Jane ◽

Michal Hires ◽

Petra Ďubjaková ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Early Stage ◽

Specific Antigen ◽

Cancer Diagnostics ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levels

Prostate Cancer and Prostatic Diseases ◽

10.1038/sj.pcan.4500957 ◽

2007 ◽

Vol 10 (3) ◽

pp. 274-278 ◽

Cited By ~ 14

Author(s):

N Tanaka ◽

K Fujimoto ◽

Y Chihara ◽

M Torimoto ◽

Y Hirao ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Prostatic Volume ◽

Predictive Parameters

Download Full-text

Effects of the somatostatin analog lanreotide on the circulating levels of chromogranin-A, prostate-specific antigen, and insulin-like growth factor-1 in advanced prostate cancer patients

The Prostate ◽

10.1002/pros.1064 ◽

2001 ◽

Vol 47 (3) ◽

pp. 205-211 ◽

Cited By ~ 21

Author(s):

Alfredo Berruti ◽

Luigi Dogliotti ◽

Alessandra Mosca ◽

Roberto Tarabuzzi ◽

Mirella Torta ◽

...

Keyword(s):

Prostate Cancer ◽

Growth Factor ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Chromogranin A ◽

Advanced Prostate Cancer ◽

Specific Antigen ◽

Somatostatin Analog ◽

Insulin Like Growth Factor ◽

Circulating Levels

Download Full-text

Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: a meta-analysis

Clinical Chemistry and Laboratory Medicine (CCLM) ◽

10.1515/cclm-2013-0675 ◽

2014 ◽

Vol 52 (5) ◽

Cited By ~ 64

Author(s):

Giorgio Treglia ◽

Luca Ceriani ◽

Ramin Sadeghi ◽

Giampiero Giovacchini ◽

Luca Giovanella

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Detection Rate ◽

Meta Analysis ◽

Specific Antigen ◽

Choline Pet ◽

Pet Ct

Download Full-text

Survival outcomes of Chinese metastatic prostate cancer patients following primary androgen deprivation therapy in relation to prostate-specific antigen nadir level

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.12313 ◽

2014 ◽

Vol 13 (2) ◽

pp. e65-e71 ◽

Cited By ~ 2

Author(s):

Jeremy Yuen Chun Teoh ◽

James Hok Leung Tsu ◽

Steffi Kar Kei Yuen ◽

Samson Yun Sang Chan ◽

Peter Ka Fung Chiu ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Androgen Deprivation Therapy ◽

Metastatic Prostate Cancer ◽

Specific Antigen ◽

Androgen Deprivation ◽

Survival Outcomes ◽

Primary Androgen Deprivation Therapy ◽

Primary Androgen Deprivation

Download Full-text

Classifying prostate cancer patients based on total prostate-specific antigen and free prostate-specific antigen features by support vector machine

Journal of Cancer Research and Therapeutics ◽

10.4103/0973-1482.172133 ◽

2016 ◽

Vol 12 (2) ◽

pp. 818 ◽

Cited By ~ 2

Author(s):

PhamThe Bao ◽

NguyenThi Hong Nhung ◽

VuTran Minh Khuong ◽

VuQuang Huy

Keyword(s):

Prostate Cancer ◽

Support Vector Machine ◽

Cancer Patients ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Support Vector ◽

Total Prostate Specific Antigen

Download Full-text